Hauri L, Muri R, Everts R, Trepp R
JIMD Rep. 2024; 65(5):354-358.
PMID: 39544686
PMC: 11558469.
DOI: 10.1002/jmd2.12446.
Piombarolo A, Ialongo C, Bizzarri M, Angeloni A
Methods Mol Biol. 2023; 2745:191-210.
PMID: 38060187
DOI: 10.1007/978-1-0716-3577-3_12.
Maissen-Abgottspon S, Muri R, Hochuli M, Reismann P, Barta A, Alptekin I
Orphanet J Rare Dis. 2023; 18(1):300.
PMID: 37740225
PMC: 10517574.
DOI: 10.1186/s13023-023-02917-w.
Lotz-Havla A, Katzdobler S, Nuscher B, Weiss K, Levin J, Havla J
Front Neurol. 2022; 13:1011470.
PMID: 36247773
PMC: 9559705.
DOI: 10.3389/fneur.2022.1011470.
OShea M, Sheehan Gilroy B, Greaney A, MacDonald A
Front Psychol. 2022; 13:983154.
PMID: 36176784
PMC: 9513515.
DOI: 10.3389/fpsyg.2022.983154.
Cognitive function in untreated subjects with mild hyperphenylalaninemia: a systematic review.
Rostampour N, Chegini R, Hovsepian S, Zamaneh F, Hashemipour M
Neurol Sci. 2022; 43(9):5593-5603.
PMID: 35729439
DOI: 10.1007/s10072-022-06194-6.
Metabolic Control of Patients with Phenylketonuria in a Portuguese Metabolic Centre Comparing Three Different Recommendations.
Kanufre V, Almeida M, Sousa Barbosa C, Carmona C, Bandeira A, Martins E
Nutrients. 2021; 13(9).
PMID: 34578995
PMC: 8469656.
DOI: 10.3390/nu13093118.
Phenylketonuria.
van Spronsen F, Blau N, Harding C, Burlina A, Longo N, Bosch A
Nat Rev Dis Primers. 2021; 7(1):36.
PMID: 34017006
PMC: 8591558.
DOI: 10.1038/s41572-021-00267-0.
A holistic approach to the patients/ Families with inborn errors of metabolism.
Burgard P
J Mother Child. 2020; 24(2):65-72.
PMID: 33179604
PMC: 8518098.
DOI: 10.34763/jmotherandchild.20202402si.2004.000010.
Similarities and differences in key diagnosis, treatment, and management approaches for PAH deficiency in the United States and Europe.
Lowe T, DeLuca J, Arnold G
Orphanet J Rare Dis. 2020; 15(1):266.
PMID: 32977849
PMC: 7519570.
DOI: 10.1186/s13023-020-01541-2.
Impact of phenylalanine on cognitive, cerebral, and neurometabolic parameters in adult patients with phenylketonuria (the PICO study): a randomized, placebo-controlled, crossover, noninferiority trial.
Trepp R, Muri R, Abgottspon S, Bosanska L, Hochuli M, Slotboom J
Trials. 2020; 21(1):178.
PMID: 32054509
PMC: 7020385.
DOI: 10.1186/s13063-019-4022-z.
Adult cognitive outcomes in phenylketonuria: explaining causes of variability beyond average Phe levels.
Romani C, Manti F, Nardecchia F, Valentini F, Fallarino N, Carducci C
Orphanet J Rare Dis. 2019; 14(1):273.
PMID: 31779649
PMC: 6883518.
DOI: 10.1186/s13023-019-1225-z.
The influence of blood phenylalanine levels on neurocognitive function in adult PKU patients.
Bartus A, Palasti F, Juhasz E, Kiss E, Simonova E, Sumanszki C
Metab Brain Dis. 2018; 33(5):1609-1615.
PMID: 29948654
DOI: 10.1007/s11011-018-0267-6.
Metabolism of amino acid neurotransmitters: the synaptic disorder underlying inherited metabolic diseases.
Kolker S
J Inherit Metab Dis. 2018; 41(6):1055-1063.
PMID: 29869166
DOI: 10.1007/s10545-018-0201-4.
Normal Growth in PKU Patients Under Low-Protein Diet in a Single-Center Cross-Sectional Study.
Matic J, Zeltner N, Haberle J
JIMD Rep. 2018; 43:1-6.
PMID: 29478217
PMC: 6323026.
DOI: 10.1007/8904_2018_92.
